dendreon corp

Public Company

Company Profile

Sector: Health Care
Industry: Biotech & Pharma
Sub-Industry: Biotech
Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.

Corporate Information

1301 2nd Avenue
Seattle, WA 98101
United States
Web url:

Board Members

Chairman Company
Xu Fang Dendreon Corp
President/Treasurer/Secretary Company
Craig Jalbert Dendreon Corp

From The Web

Key Executives

Chief Executive Officer
Exec VP/Chief Medical Officer
Exec VP:Corporate Communications
Exec VP:Technical Operations
VP/Chief Marketing Officer
VP/Chief Customer Officer

Sponsored Financial Commentaries

More From The Web